Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
PTEN Phosphohydrolase | 14 | 2020 | 1142 | 0.850 |
Why?
|
Drug Evaluation, Preclinical | 3 | 2015 | 1375 | 0.420 |
Why?
|
Tumor Suppressor Protein p53 | 8 | 2018 | 2949 | 0.380 |
Why?
|
TOR Serine-Threonine Kinases | 4 | 2016 | 2110 | 0.350 |
Why?
|
Neoplasm Proteins | 4 | 2021 | 3707 | 0.330 |
Why?
|
Leukemia, Promyelocytic, Acute | 2 | 2021 | 236 | 0.320 |
Why?
|
Drug Resistance, Neoplasm | 7 | 2021 | 5172 | 0.320 |
Why?
|
Prostatic Neoplasms | 11 | 2020 | 11126 | 0.320 |
Why?
|
Disease Models, Animal | 11 | 2020 | 18034 | 0.310 |
Why?
|
Tumor Suppressor Proteins | 4 | 2019 | 2850 | 0.300 |
Why?
|
Anilides | 2 | 2020 | 408 | 0.270 |
Why?
|
Mice | 40 | 2024 | 81201 | 0.270 |
Why?
|
BH3 Interacting Domain Death Agonist Protein | 1 | 2005 | 92 | 0.270 |
Why?
|
Antineoplastic Agents | 7 | 2024 | 13693 | 0.260 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 6 | 2024 | 5223 | 0.260 |
Why?
|
Cytochromes c | 1 | 2005 | 180 | 0.260 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 2 | 2018 | 104 | 0.250 |
Why?
|
Pericytes | 2 | 2018 | 293 | 0.230 |
Why?
|
RNA, Ribosomal | 2 | 2019 | 245 | 0.230 |
Why?
|
Cell Line, Tumor | 20 | 2021 | 16690 | 0.220 |
Why?
|
Indoles | 3 | 2019 | 1839 | 0.220 |
Why?
|
Pantothenic Acid | 1 | 2022 | 18 | 0.220 |
Why?
|
Animals | 46 | 2024 | 168768 | 0.220 |
Why?
|
Coenzyme A | 1 | 2022 | 39 | 0.210 |
Why?
|
Neoplasm Metastasis | 4 | 2018 | 4851 | 0.210 |
Why?
|
Nuclear Proteins | 6 | 2019 | 5856 | 0.210 |
Why?
|
Gene Expression Regulation, Neoplastic | 13 | 2021 | 8432 | 0.210 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 2 | 2005 | 1434 | 0.200 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2022 | 130 | 0.200 |
Why?
|
Computational Biology | 1 | 2013 | 3519 | 0.200 |
Why?
|
Clinical Trials as Topic | 2 | 2015 | 7914 | 0.200 |
Why?
|
Nipples | 1 | 2023 | 219 | 0.190 |
Why?
|
Ubiquitin-Protein Ligases | 2 | 2021 | 1862 | 0.190 |
Why?
|
Caspases | 1 | 2004 | 928 | 0.190 |
Why?
|
Androgen Receptor Antagonists | 1 | 2021 | 114 | 0.180 |
Why?
|
Sesquiterpenes | 1 | 2021 | 177 | 0.180 |
Why?
|
Lipogenesis | 2 | 2020 | 212 | 0.180 |
Why?
|
Glucose Transporter Type 3 | 1 | 2019 | 16 | 0.180 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13104 | 0.170 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2021 | 2938 | 0.170 |
Why?
|
Trans-Activators | 1 | 2009 | 2926 | 0.170 |
Why?
|
Dyskeratosis Congenita | 1 | 2019 | 72 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-akt | 6 | 2022 | 2504 | 0.170 |
Why?
|
Mutation | 10 | 2021 | 29786 | 0.170 |
Why?
|
Xenograft Model Antitumor Assays | 7 | 2021 | 3554 | 0.170 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2021 | 520 | 0.170 |
Why?
|
Thyroid Neoplasms | 3 | 2018 | 2282 | 0.160 |
Why?
|
Databases, Factual | 1 | 2013 | 7730 | 0.160 |
Why?
|
Sterol Regulatory Element Binding Proteins | 1 | 2018 | 27 | 0.160 |
Why?
|
Cytoplasm | 3 | 2013 | 1536 | 0.160 |
Why?
|
Organoids | 2 | 2021 | 701 | 0.160 |
Why?
|
Caveolin 1 | 1 | 2019 | 263 | 0.150 |
Why?
|
Lipoylation | 1 | 2018 | 72 | 0.150 |
Why?
|
Protein Phosphatase 1 | 1 | 2018 | 137 | 0.150 |
Why?
|
Anticarcinogenic Agents | 1 | 2019 | 253 | 0.150 |
Why?
|
Pyridines | 2 | 2020 | 2825 | 0.150 |
Why?
|
Growth and Development | 1 | 2016 | 52 | 0.140 |
Why?
|
Signal Transduction | 14 | 2022 | 23404 | 0.140 |
Why?
|
Leukemia, Myeloid, Acute | 5 | 2019 | 3524 | 0.140 |
Why?
|
Molecular Targeted Therapy | 4 | 2021 | 2725 | 0.140 |
Why?
|
Apoptosis | 5 | 2021 | 9724 | 0.140 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2019 | 436 | 0.140 |
Why?
|
DNA, Intergenic | 1 | 2016 | 107 | 0.140 |
Why?
|
Positive Transcriptional Elongation Factor B | 1 | 2016 | 42 | 0.140 |
Why?
|
Neoplasms | 5 | 2019 | 21696 | 0.140 |
Why?
|
Proto-Oncogene Proteins B-raf | 2 | 2018 | 2043 | 0.140 |
Why?
|
Tretinoin | 1 | 2019 | 517 | 0.140 |
Why?
|
Mice, Transgenic | 10 | 2021 | 9735 | 0.140 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 315 | 0.140 |
Why?
|
Benzimidazoles | 1 | 2021 | 850 | 0.130 |
Why?
|
HMGB1 Protein | 1 | 2017 | 134 | 0.130 |
Why?
|
RNA-Binding Proteins | 2 | 2016 | 1903 | 0.130 |
Why?
|
Fertility | 1 | 2020 | 781 | 0.130 |
Why?
|
Genetic Pleiotropy | 1 | 2016 | 182 | 0.130 |
Why?
|
Animal Husbandry | 1 | 2015 | 66 | 0.130 |
Why?
|
Cell Proliferation | 9 | 2022 | 10483 | 0.130 |
Why?
|
Pyrazines | 1 | 2021 | 1230 | 0.130 |
Why?
|
RNA, Messenger | 5 | 2019 | 13035 | 0.130 |
Why?
|
Chemokine CXCL12 | 1 | 2017 | 465 | 0.120 |
Why?
|
Receptors, Androgen | 1 | 2021 | 1058 | 0.120 |
Why?
|
Phthalazines | 1 | 2017 | 363 | 0.120 |
Why?
|
Hematopoiesis | 1 | 2004 | 2073 | 0.120 |
Why?
|
Transcription Factors | 5 | 2021 | 12207 | 0.120 |
Why?
|
Elafin | 1 | 2014 | 33 | 0.120 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2018 | 644 | 0.120 |
Why?
|
Multiprotein Complexes | 3 | 2016 | 1120 | 0.120 |
Why?
|
Mice, SCID | 4 | 2021 | 2716 | 0.120 |
Why?
|
Hemangiopericytoma | 1 | 2014 | 77 | 0.120 |
Why?
|
Epigenomics | 1 | 2019 | 903 | 0.120 |
Why?
|
Hematopoietic Stem Cells | 2 | 2019 | 3390 | 0.120 |
Why?
|
Cell Transformation, Neoplastic | 5 | 2018 | 2943 | 0.120 |
Why?
|
Mice, Knockout | 8 | 2021 | 14561 | 0.110 |
Why?
|
Protein Kinase Inhibitors | 4 | 2020 | 5534 | 0.110 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 2 | 2022 | 437 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2019 | 988 | 0.110 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2021 | 1692 | 0.110 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2019 | 871 | 0.110 |
Why?
|
Public Sector | 1 | 2015 | 265 | 0.110 |
Why?
|
RNA | 2 | 2021 | 2749 | 0.110 |
Why?
|
Pancreatic Neoplasms | 2 | 2021 | 5263 | 0.110 |
Why?
|
Genes, Neoplasm | 1 | 2015 | 376 | 0.110 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2015 | 431 | 0.110 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2020 | 1660 | 0.110 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2021 | 1636 | 0.110 |
Why?
|
Drug Repositioning | 1 | 2015 | 230 | 0.110 |
Why?
|
Gallbladder Neoplasms | 1 | 2014 | 182 | 0.110 |
Why?
|
NF-kappa B | 1 | 2021 | 2499 | 0.100 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2014 | 440 | 0.100 |
Why?
|
Therapies, Investigational | 1 | 2013 | 112 | 0.100 |
Why?
|
Eukaryotic Initiation Factors | 1 | 2012 | 92 | 0.100 |
Why?
|
Private Sector | 1 | 2015 | 392 | 0.100 |
Why?
|
Muscles | 1 | 2016 | 1614 | 0.100 |
Why?
|
Naphthyridines | 1 | 2012 | 118 | 0.100 |
Why?
|
Enzyme Activation | 1 | 2018 | 3702 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1788 | 0.100 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2015 | 324 | 0.100 |
Why?
|
Humans | 49 | 2023 | 744366 | 0.100 |
Why?
|
DNA-Binding Proteins | 2 | 2019 | 9647 | 0.100 |
Why?
|
Epithelial Cells | 2 | 2021 | 3690 | 0.090 |
Why?
|
Neutrophils | 2 | 2020 | 3721 | 0.090 |
Why?
|
Histones | 1 | 2021 | 2598 | 0.090 |
Why?
|
MAP Kinase Signaling System | 1 | 2018 | 1525 | 0.090 |
Why?
|
Lysosomes | 3 | 2021 | 893 | 0.090 |
Why?
|
Ribosomes | 1 | 2013 | 500 | 0.090 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 491 | 0.090 |
Why?
|
Myeloid Cells | 2 | 2018 | 810 | 0.090 |
Why?
|
Breast Neoplasms | 4 | 2023 | 20824 | 0.090 |
Why?
|
Chromatin | 1 | 2021 | 2933 | 0.080 |
Why?
|
Nanoparticles | 1 | 2020 | 1905 | 0.080 |
Why?
|
HEK293 Cells | 4 | 2019 | 4208 | 0.080 |
Why?
|
Purines | 1 | 2012 | 594 | 0.080 |
Why?
|
Oncogene Proteins | 2 | 2016 | 749 | 0.080 |
Why?
|
Interprofessional Relations | 1 | 2015 | 1011 | 0.080 |
Why?
|
Oncogenes | 2 | 2021 | 1265 | 0.080 |
Why?
|
Drug Approval | 1 | 2015 | 742 | 0.080 |
Why?
|
Immunotherapy | 2 | 2021 | 4446 | 0.080 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 3590 | 0.080 |
Why?
|
Regeneration | 1 | 2016 | 1485 | 0.080 |
Why?
|
Medical Informatics | 1 | 2015 | 745 | 0.080 |
Why?
|
Sarcoma | 1 | 2019 | 1897 | 0.080 |
Why?
|
Gene Expression Regulation | 3 | 2021 | 12073 | 0.070 |
Why?
|
Drug Discovery | 1 | 2015 | 1058 | 0.070 |
Why?
|
DNA | 1 | 2021 | 7294 | 0.070 |
Why?
|
Piperazines | 1 | 2017 | 2488 | 0.070 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2011 | 1213 | 0.070 |
Why?
|
Embryonic Stem Cells | 1 | 2013 | 1295 | 0.070 |
Why?
|
bcl-2 Homologous Antagonist-Killer Protein | 1 | 2005 | 75 | 0.070 |
Why?
|
Mass Spectrometry | 3 | 2022 | 2204 | 0.070 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2009 | 651 | 0.070 |
Why?
|
Androgens | 1 | 2013 | 1281 | 0.070 |
Why?
|
Open Reading Frames | 2 | 2020 | 811 | 0.070 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4751 | 0.060 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 9445 | 0.060 |
Why?
|
Models, Biological | 6 | 2018 | 9584 | 0.060 |
Why?
|
Two-Hybrid System Techniques | 1 | 2005 | 464 | 0.060 |
Why?
|
Genome, Human | 1 | 2018 | 4420 | 0.060 |
Why?
|
TNF-Related Apoptosis-Inducing Ligand | 1 | 2005 | 197 | 0.060 |
Why?
|
Mice, Inbred C57BL | 6 | 2019 | 21833 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1940 | 0.060 |
Why?
|
Down-Regulation | 1 | 2012 | 3001 | 0.060 |
Why?
|
bcl-2-Associated X Protein | 1 | 2005 | 295 | 0.060 |
Why?
|
Mice, Nude | 2 | 2021 | 3689 | 0.060 |
Why?
|
Peptides | 1 | 2016 | 4410 | 0.060 |
Why?
|
Androgen Antagonists | 1 | 2013 | 1377 | 0.060 |
Why?
|
Gene Knockout Techniques | 2 | 2019 | 808 | 0.060 |
Why?
|
Angiogenesis Inhibitors | 1 | 2014 | 2038 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2007 | 705 | 0.060 |
Why?
|
Pyrimidines | 1 | 2016 | 2943 | 0.060 |
Why?
|
Ubiquitination | 2 | 2019 | 1012 | 0.060 |
Why?
|
Male | 21 | 2021 | 350115 | 0.060 |
Why?
|
RNA, Neoplasm | 1 | 2006 | 769 | 0.060 |
Why?
|
Proteome | 1 | 2013 | 1798 | 0.060 |
Why?
|
Keratin-7 | 1 | 2023 | 57 | 0.060 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1879 | 0.060 |
Why?
|
Endosomes | 2 | 2016 | 519 | 0.060 |
Why?
|
Proteins | 3 | 2018 | 6100 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2004 | 743 | 0.050 |
Why?
|
Acetyl Coenzyme A | 1 | 2022 | 74 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2005 | 1723 | 0.050 |
Why?
|
Equilibrative Nucleoside Transporter 1 | 1 | 2021 | 17 | 0.050 |
Why?
|
Tumor Cells, Cultured | 2 | 2020 | 6313 | 0.050 |
Why?
|
Telomerase | 1 | 2006 | 730 | 0.050 |
Why?
|
Gene Amplification | 2 | 2018 | 1063 | 0.050 |
Why?
|
Transforming Growth Factor beta | 1 | 2009 | 2007 | 0.050 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1707 | 0.050 |
Why?
|
Blotting, Western | 2 | 2009 | 5181 | 0.050 |
Why?
|
Gene Silencing | 3 | 2018 | 1539 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3505 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2023 | 644 | 0.050 |
Why?
|
Diagnostic Imaging | 1 | 2015 | 3508 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 352 | 0.050 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2005 | 1157 | 0.050 |
Why?
|
Gene Expression | 1 | 2013 | 7798 | 0.050 |
Why?
|
Proteomics | 1 | 2013 | 3638 | 0.050 |
Why?
|
RNA, Small Nucleolar | 1 | 2019 | 31 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1185 | 0.040 |
Why?
|
HeLa Cells | 1 | 2005 | 3130 | 0.040 |
Why?
|
Spermatogenesis | 1 | 2020 | 262 | 0.040 |
Why?
|
U937 Cells | 1 | 2019 | 268 | 0.040 |
Why?
|
Leukemia | 1 | 2007 | 1510 | 0.040 |
Why?
|
Amino Acid Motifs | 1 | 2021 | 937 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3848 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2019 | 321 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 11525 | 0.040 |
Why?
|
COS Cells | 1 | 2020 | 1161 | 0.040 |
Why?
|
Cysteine | 1 | 2022 | 873 | 0.040 |
Why?
|
Melanoma | 1 | 2016 | 5511 | 0.040 |
Why?
|
HL-60 Cells | 1 | 2018 | 365 | 0.040 |
Why?
|
Deoxycytidine | 1 | 2021 | 826 | 0.040 |
Why?
|
Drug Synergism | 1 | 2021 | 1794 | 0.040 |
Why?
|
RNA Interference | 1 | 2005 | 2890 | 0.040 |
Why?
|
Endocytosis | 1 | 2021 | 985 | 0.040 |
Why?
|
Cell Communication | 1 | 2024 | 1621 | 0.040 |
Why?
|
Methylation | 1 | 2019 | 1106 | 0.040 |
Why?
|
K562 Cells | 1 | 2018 | 635 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2021 | 1730 | 0.030 |
Why?
|
Cytarabine | 1 | 2018 | 692 | 0.030 |
Why?
|
Benzylamines | 1 | 2017 | 223 | 0.030 |
Why?
|
RNA Splicing | 1 | 2021 | 908 | 0.030 |
Why?
|
Hematologic Neoplasms | 1 | 2008 | 1832 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2022 | 2027 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2021 | 1152 | 0.030 |
Why?
|
Heterocyclic Compounds | 1 | 2017 | 249 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 5023 | 0.030 |
Why?
|
Tumor Burden | 1 | 2021 | 1915 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2006 | 3464 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 944 | 0.030 |
Why?
|
Membrane Glycoproteins | 1 | 2005 | 3771 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2017 | 486 | 0.030 |
Why?
|
Genetic Heterogeneity | 1 | 2018 | 733 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2005 | 4424 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2019 | 971 | 0.030 |
Why?
|
Microtubules | 1 | 2020 | 1089 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2018 | 674 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2019 | 1117 | 0.030 |
Why?
|
Polysaccharides | 1 | 2020 | 1059 | 0.030 |
Why?
|
Heterozygote | 2 | 2011 | 2804 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1889 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1485 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1276 | 0.030 |
Why?
|
Protein Binding | 1 | 2005 | 9384 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2018 | 783 | 0.030 |
Why?
|
Administration, Oral | 1 | 2021 | 3914 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 399 | 0.030 |
Why?
|
Exons | 1 | 2019 | 2439 | 0.030 |
Why?
|
Melanoma, Experimental | 1 | 2016 | 561 | 0.030 |
Why?
|
Valine | 1 | 2014 | 413 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2020 | 3616 | 0.030 |
Why?
|
Adenosine Triphosphatases | 1 | 2016 | 839 | 0.030 |
Why?
|
Gene Duplication | 1 | 2013 | 329 | 0.030 |
Why?
|
Testosterone | 1 | 2023 | 2419 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 1038 | 0.030 |
Why?
|
Nanostructures | 1 | 2017 | 551 | 0.030 |
Why?
|
Phenylthiohydantoin | 1 | 2013 | 193 | 0.030 |
Why?
|
Organ Specificity | 1 | 2016 | 2008 | 0.030 |
Why?
|
Cell Membrane | 1 | 2021 | 3749 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 12952 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2013 | 684 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2024 | 3486 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5895 | 0.020 |
Why?
|
Phosphorylation | 1 | 2022 | 8436 | 0.020 |
Why?
|
Orchiectomy | 1 | 2013 | 474 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2021 | 2917 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2182 | 0.020 |
Why?
|
Amino Acids | 1 | 2016 | 1737 | 0.020 |
Why?
|
BRCA1 Protein | 1 | 2017 | 1149 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6539 | 0.020 |
Why?
|
Genes, myc | 1 | 2011 | 399 | 0.020 |
Why?
|
Fatty Acids | 1 | 2018 | 1809 | 0.020 |
Why?
|
Alleles | 2 | 2013 | 6933 | 0.020 |
Why?
|
Cell Line | 1 | 2004 | 16000 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2016 | 1005 | 0.020 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2010 | 137 | 0.020 |
Why?
|
Mice, Inbred CBA | 1 | 2009 | 448 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2014 | 1169 | 0.020 |
Why?
|
Pheochromocytoma | 1 | 2011 | 337 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1656 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4222 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1632 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2021 | 4554 | 0.020 |
Why?
|
Cell Movement | 1 | 2020 | 5218 | 0.020 |
Why?
|
Female | 8 | 2023 | 380193 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10252 | 0.020 |
Why?
|
Nitriles | 1 | 2013 | 955 | 0.020 |
Why?
|
Energy Metabolism | 1 | 2019 | 2897 | 0.020 |
Why?
|
Mammals | 1 | 2013 | 1143 | 0.020 |
Why?
|
Benzamides | 1 | 2013 | 1379 | 0.020 |
Why?
|
Adenovirus E1A Proteins | 1 | 2007 | 76 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2013 | 19233 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2009 | 898 | 0.020 |
Why?
|
Glucose | 1 | 2019 | 4398 | 0.020 |
Why?
|
Treatment Failure | 1 | 2013 | 2618 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2013 | 63107 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 2086 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1252 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2010 | 1097 | 0.020 |
Why?
|
Homozygote | 1 | 2010 | 1787 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2017 | 2962 | 0.020 |
Why?
|
Zebrafish | 1 | 2016 | 2996 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2018 | 4666 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1701 | 0.010 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6364 | 0.010 |
Why?
|
Mitosis | 1 | 2009 | 1208 | 0.010 |
Why?
|
Cell Separation | 1 | 2009 | 1751 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 2011 | 1376 | 0.010 |
Why?
|
Macrophages | 1 | 2018 | 5660 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2751 | 0.010 |
Why?
|
Cell Cycle | 1 | 2011 | 2967 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2010 | 2126 | 0.010 |
Why?
|
Base Sequence | 1 | 2013 | 12797 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7721 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 2383 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2013 | 13814 | 0.010 |
Why?
|
Lung | 1 | 2019 | 9857 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2013 | 18111 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2018 | 10183 | 0.010 |
Why?
|
Prognosis | 1 | 2020 | 29060 | 0.010 |
Why?
|
DNA Damage | 1 | 2010 | 2432 | 0.010 |
Why?
|
Lymphoma, B-Cell | 1 | 2006 | 931 | 0.010 |
Why?
|
Models, Genetic | 1 | 2010 | 3493 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4162 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2009 | 5974 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2009 | 5867 | 0.010 |
Why?
|
Myelodysplastic Syndromes | 1 | 2008 | 1352 | 0.010 |
Why?
|
Middle Aged | 2 | 2023 | 213390 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2013 | 11486 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2014 | 9240 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 57776 | 0.010 |
Why?
|
Colonic Neoplasms | 1 | 2006 | 2542 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2006 | 11366 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2010 | 17446 | 0.000 |
Why?
|
Aged | 1 | 2020 | 163288 | 0.000 |
Why?
|
Adult | 1 | 2020 | 214052 | 0.000 |
Why?
|